amaz-02
Botanicalexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2016 (NCT02655393)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- amaz-02
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03464500 | N/A | Mar 6, 2018 | Amazentis SA, KGK Science Inc. |
| NCT03283462 | N/A | Jan 15, 2018 | Amazentis SA, Department of Veteran Affairs, Synteract, Inc., University of Washington |
| NCT02655393 | Phase 1 | Jan 1, 2016 | Amazentis SA, Eurofins |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amazentis SA | For profit | 3 | 3 | 2 | 2016 |
| Department of Veteran Affairs | Government | 1 | 0 | 1 | 2018 |
| Eurofins | For profit | 1 | 0 | 1 | 2016 |
| KGK Science Inc. | For profit | 1 | 0 | 1 | 2018 |
| Synteract, Inc. | For profit | 1 | 0 | 1 | 2018 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2018 |
6 organizations
Page 1 / 1